Client Profile
A $70B Fortune 100 Healthcare and Pharmaceutical Conglomerate
Business Issue
- Company undertaking a technology stack expansion to support business growth
- Planning for continual transformation and enhancement to its business processes
and other operational objectives
Services & Results
UpperEdge supported the evaluation of multiple technology licensing options with various
Unlimited License Agreement (ULA) term durations, resulting in the following:
- Attained a best-in-class deal construct
- Achieved a $2.3M TCO reduction while adding another year to the ULA term
- Attained 8 years of price protection
- Resolved prior multi-million-dollar audit dispute for no charge
